Longitudinal studies of cardiac troponin I concentrations in serum from male cynomolgus monkeys: resting values and effects of oral and intravenous dosing on biologic variability.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Veterinary clinical pathology

• Publication date

  2015-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/vcp.12272PMID 26175009
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Is it time to do away with the 99th percentile for cardiac troponin in the diagnosis of acute coronary syndrome and the assessment of cardiac risk?

  2014cited by this paper
• Comparison of Cardiac Troponin I and T, Including the Evaluation of an Ultrasensitive Assay, as Indicators of Doxorubicin-induced Cardiotoxicity

  2013cited by this paper
• Variation of cardiac troponin I and T measured with sensitive assays in emergency department patients with noncardiac chest pain.

  2012cited by this paper
• Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice.

  2009cited by this paper
• Longitudinal Studies of Cardiac Troponin-I Concentrations in Serum from Male Sprague Dawley Rats: Baseline Reference Ranges and Effects of Handling and Placebo Dosing on Biological Variability

  2009influential reference
• Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure.

  2009cited by this paper
• Analytical characteristics of commercial cardiac troponin I and T immunoassays in serum from rats, dogs, and monkeys with induced acute myocardial injury.

  2008cited by this paper
• Short-and Long-Term Biological Variation in Cardiac Troponin I with a High-Sensitivity Assay : Implications for Clinical Practice

  2008cited by this paper
• Ultrasensitive Cross-species Measurement of Cardiac Troponin-I Using the Erenna Immunoassay System

  2008influential reference
• Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity.

  2008cited by this paper
• Universal definition of myocardial infarction.

  2007cited by this paper
• Universal definition of myocardial infarction.

  2007cited by this paper
• Development and preliminary clinical validation of a high sensitivity assay for cardiac troponin using a capillary flow (single molecule) fluorescence detector.

  2006cited by this paper
• A comparison of two approaches for selecting covariance structures in the analysis of repeated measurements

  1998cited by this paper
• Small sample inference for fixed effects from restricted maximum likelihood.

  1997cited by this paper

• Preclinical cardiovascular safety assessment of pharmacology - toxicology relationship for a set of novel kinase inhibitors.

  2024cites this paper
• [In vivo integrated safety assessment of the cardiovascular system in drug development].

  2022cites this paper
• Scientific and Regulatory Policy Committee Points to Consider: Integration of Clinical Pathology Data With Anatomic Pathology Data in Nonclinical Toxicology Studies.

  2022cites this paper
• Scientific and Regulatory Policy Committee Points to Consider: Integration of Clinical Pathology Data With Anatomic Pathology Data in Nonclinical Toxicology Studies

  2022cites this paper
• Selected Resources for Pathology Evaluation of Nonhuman Primates in Nonclinical Safety Assessment

  2022cites this paper
• Automated Blood Sampling in a Canine Telemetry Cardiovascular Model.

  2021cites this paper
• Lack of Toxicity in Nonhuman Primates Receiving Clinically Relevant Doses of an AAV9.U7snRNA Vector Designed to Induce DMD Exon 2 Skipping

  2021cites this paper
• Automated blood sampling in canine telemetry studies: Enabling enhanced assessments of cardiovascular liabilities and safety margins.

  2021cites this paper
• Automated blood sampling in canine telemetry model: Enhanced assessment of immune liabilities.

  2021cites this paper
• Safety pharmacology during the COVID pandemic

  2021cites this paper
• Automated blood sampling in canine telemetry studies: Enabling enhanced assessments of cardiovascular liabilities and safety margins.

  2021cites this paper
• Transthoracic echocardiography and cardiac biomarkers in healthy captive male and female squirrel monkeys (Saimiri spp.)

  2020cites this paper
• Comprehensive analysis of cardiac function, blood biomarkers and histopathology for milrinone-induced cardiotoxicity in cynomolgus monkeys.

  2020cites this paper
• Assessment of Cardiac Troponin I Responses in Nonhuman Primates during Restraint, Blood Collection, and Dosing in Preclinical Safety Studies

  2017influential citation
• Translational trio of myocardial biomarkers for prediction, monitoring and controlling toxicologic response: Mechanistic (high content analysis), leakage (high-sensitivity cardiac troponin I) and function biomarkers (B-type natriuretic peptide)

  2017cites this paper
• Deciphering Sources of Variability in Clinical Pathology—It’s Not Just about the Numbers

  2017cites this paper
• Ultrasensitive bioanalysis: current status and future trends.

  2017cites this paper
• Effects of repeated restraint and blood sampling with needle injection on blood cardiac troponins in rats, dogs, and cynomolgus monkeys

  2017influential citation
• Technological Advances in Cardiovascular Safety Assessment Decrease Preclinical Animal Use and Improve Clinical Relevance.

  2016cites this paper
• Automated Microsampling Technologies and Enhancements in the 3Rs.

  2016influential citation